Levita Magnetics is a pioneering player in the Biotechnology and Health Care industries, established in 2011 and headquartered in the United States. The company is renowned for its commitment to enhancing patient outcomes through its proprietary Magnetic Surgery® platform, which represents a notable advancement in minimally invasive surgical techniques.
The innovation of Levita Magnetics lies in its ability to reduce the surgical footprint by minimizing the number of incisions required, thereby promising better cosmetic results, reduced pain, and swifter recovery times. Their technology is currently cleared for both laparoscopic cholecystectomy and bariatric procedures, underscoring its broad applicability and potential for expansion.
The company secured a $26.00M Series C investment on 11 August 2022, backed by notable investors such as Carao Ventures, Ballast Capital, and MedTex Ventures. This funding round highlights significant investor confidence in Levita's disruptive potential in the surgical space.